Table 1 of
Javadzadeh, Mol Vis 2013; 19:62-68. Table 1 of
Javadzadeh, Mol Vis 2013; 19:62-68.
Table 1. Demographic and baseline characteristics of the patients [mean±SD (median, interquartile range)].
| Parameters | Group Ca-D (n=45) | Group placebo (n=45) | P value |
|---|---|---|---|
| Gender (male:female) | 0.604861 | 0.686806 | 0.82 |
| Age (years) | 59.04±8.29 (60, 53–64) | 59.33±5.83 (60, 55–64) | 0.84 |
| Proliferative DR: n (%) | 37 (82.2) | 36 (80) | 1 |
| Severe non-proliferative DR: n (%) | 8 (17.8) | 9 (20) | 1 |
| BMI (kg/m2) | 27.56±4.27 (27.74,24.18–30.45) | 27.51±4.44(27.63,24.26–29.82) | 0.95 |
| Systolic BP (mmHg) | 137.55±21.60 (140,120–150) | 137.00±18.41(135, 125–142.5) | 0.89 |
| Diastolic BP (mmHg) | 77.55±12.21 (80, 67.5–80) | 76.88±10.72 (80, 70–82.5) | 0.58 |
| Duration of DR (years) | 5.13±2.88 (5, 2.5–8) | 4.74±3.06 (4, 3–6) | 0.53 |
| Duration of DM (years) | 16.28±6.93 (15, 10–20) | 15.48±5.99 (15, 11–20) | 0.56 |
| Visual acuity (logMAR) | 0.69±0.25 (0.62, 0.45–0.95) | 0.72±0.23 (0.75, 0.53–1) | 0.42 |